Radical
prostatectomy
is surgery to remove the entire prostate gland, the attached
seminal vesicles (a pair of glands that produce part
of semen) and the vas deferens (the muscular
cord that pumps sperm from the testicles to the urethra).
Radical prostatectomy is an option when prostate cancer is
localized to the prostate gland. The goal is to remove the
cancer completely before it has a chance to spread from the
prostate to other parts of the body.
Radical prostatectomy is a particularly effective treatment for men with Gleason scores below 7 and whose cancers are confined to the prostate or have penetrated the capsule but not spread to the seminal vesicles. A recent study of over 1300 men undergoing radical prostatectomy was conducted to determine their status five years after surgery. Based on PSA readings, over 90 percent with organ-confined cancer remained cancer-free. Over 70 percent whose cancer extended outside the prostatic capsule remained cancer-free, if it had not invaded the seminal vesicles¹.
Other
studies have also reported high rates of metastasis-free survival
after 10 years when radical prostatectomy is performed by
a skilled, experienced surgeon and the cancer is organ-confined
and not aggressive.
Appropriate candidates for radical prostatectomy
Those who should consider other treatments
The prostate gland is located deep inside the pelvis and surrounded by delicate organs, nerves and tissues. These include the rectum, the bladder, the sphincter (muscles controlling the flow of urine), blood vessels and the nerves that control erections.
Surgical procedures to remove the prostate include:
¹Eastham JA, Scardino PT. Radical prostatectomy for clinical stage T1 and T2 prostate cancer. In NJ Vogelzang, PT Scardino, WU Shipley, DS Coffey (Eds.), Comprehensive Textbook of Genitourinary Oncology (2nd ed.). Philadelphia: Lippincott Williams & Wilkins; 2000.
The Prostate Cancer pages of this Web site are part of the Comprehensive Prostate Cancer Awareness Program (CPCAP), a major regional effort to reduce the rates of death and illness caused by prostate cancer in southwestern Pennsylvania. Funding for CPCAP is provided by a grant from the Commonwealth of Pennsylvania.
About This Web Site
|
Give Us Your Feedback
|
Privacy Statement
|
Disclaimer
|
Informatics Web Resources
©
UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811
|
PCI-INFO@upmc.edu
|
Send questions and comments to UPCIwebupdates@upmc.edu

